Ablation of Subcutaneous Contraceptive Implants in the Operating Room (TAICS)
Technical Description of the Ablation of Subcutaneous Contraceptive Implants in the Operating Room
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Bron, France, 69677
- Recruiting
- Gynaecology Department, Hôpital Femme Mère Enfant, Hospices Civils de Lyon
-
Principal Investigator:
- Gautier CHENE, MD
-
Contact:
- Gautier CHENE, MD
- Phone Number: +33 04 72 35 58 70
- Email: gautier.chene@chu-lyon.fr
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- women over 18
- patient who underwent explantation of a subcutaneous contraceptive implant in the gynecology operating room
- intervention between 2018 and 2022
- person having expressed his non-opposition
Exclusion Criteria:
- explantation outside the operating room
- inability to understand the information given
- person deprived of liberty
- person under guardianship
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
subcutaneous contraceptive implants
patients who have benefited from explantation of a subcutaneous contraceptive implant in the gynecology operating room
|
describe techniques for pre-operative visualization of subcutaneous contraceptive implants
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ultrasound for visualization of implants
Time Frame: preoperatively
|
Percentage of patients with an ultrasound to visualize the implants
|
preoperatively
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 69HCL22_1032
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.